Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
Public ClinicalTrials.gov record NCT02347774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a trial of 12 weeks of treatment with nebulized SUN-101 using an Investigational eFlow® Closed System (CS) nebulizer in subjects with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD 2014) guidelines.
Study identification
- NCT ID
- NCT02347774
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 641 participants
Conditions and interventions
Conditions
Interventions
- SUN-101 50 mcg BID eFlow (CS) nebulizer Drug
- SUN-101 25 mcg BID eFlow (CS) nebulizer Drug
- Placebo eFlow (CS) nebulizer Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Nov 30, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Mar 12, 2018
2015
United States locations
- U.S. sites
- 45
- U.S. states
- 21
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SEC Lung, LLC | Andalusia | Alabama | 36420 | — |
| Jasper Summit Research, LLC | Jasper | Alabama | 35501 | — |
| Pulmonary Associates, PA | Glendale | Arizona | 85306 | — |
| Phoenix Medical Research Institute, LLC | Peoria | Arizona | 85381 | — |
| Clinical Research Consortium | Tempe | Arizona | 85283 | — |
| Center for Clinical Trials of Sacramento, Inc. | Sacramento | California | 95823 | — |
| Institute of HealthCare Assessment, Inc | San Diego | California | 92120 | — |
| Innovative Clinical Research | Broomfield | Colorado | 80023 | — |
| IMMUNOe International Research Centers | Centennial | Colorado | 80112 | — |
| Longmont Pulmonary and Critical Care | Longmont | Colorado | 80501 | — |
| Ribo Research, LLC dba Peninsula Research Inc. | Ormond Beach | Florida | 32174 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Pulmonary Care Research Group, PA | Winter Park | Florida | 32789 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Duluth Biomedical Research, LLC | Duluth | Georgia | 30096 | — |
| Southeast Regional Research Group | Rincon | Georgia | 31326 | — |
| Asthma and Allergy Center of Chicago, SC | River Forest | Illinois | 60305 | — |
| LaPorte County Institute for Clinical Research | Michigan City | Indiana | 46360 | — |
| George Stanley Walker, MD | New Orleans | Louisiana | 70115 | — |
| Minnesota Lung Center | Minneapolis | Minnesota | 55407 | — |
| CAR.E. Clinical Research | St Louis | Missouri | 63141 | — |
| The Clinical Research Center, LLC | St Louis | Missouri | 63141 | — |
| Delaware Valley Clinical Research | Marlton | New Jersey | 08053 | — |
| Clinical Research of Gastonia | Gastonia | North Carolina | 28054 | — |
| PharmQuest | Greensboro | North Carolina | 27408 | — |
| Clinical Research of Lake Norman | Huntersville | North Carolina | 28078 | — |
| PMG Research of Raleigh, LLC | Raleigh | North Carolina | 27609 | — |
| Southeastern Research Center, LLC | Winston-Salem | North Carolina | 27103 | — |
| Liliestol Research LLC | Fargo | North Dakota | 58103 | — |
| New Horizons Clinical Research | Cincinnati | Ohio | 45242 | — |
| Remington-Davis, Inc | Columbus | Ohio | 43215 | — |
| Sridhar Guduri, MD | Dublin | Ohio | 43016 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Allergy Associates Research Center | Portland | Oregon | 97202 | — |
| Lowcountry Lung and Critical Care, PA | Charleston | South Carolina | 29406 | — |
| Easley Clinical Research | Easley | South Carolina | 29640 | — |
| Gaffney Pharmaceutical Research | Gaffney | South Carolina | 29340 | — |
| Spectrum Medical Research, LLC | Gaffney | South Carolina | 29341 | — |
| Clinical Research of Charleston | Mt. Pleasant | South Carolina | 29464 | — |
| CU Pharmaceutical Research | Rock Hill | South Carolina | 29732 | — |
| Hope Clinical Research | Seneca | South Carolina | 29678 | — |
| New Phase Research & Development | Knoxville | Tennessee | 37919 | — |
| Health Research of Hampton Roads, Inc. | Newport News | Virginia | 23606 | — |
| Pulmonary Associates of Richmond, Inc | Richmond | Virginia | 23229 | — |
| Multicare Pulmonary Specialists | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02347774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2018 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02347774 live on ClinicalTrials.gov.